Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Mar;19(3):999–1012. doi: 10.1128/iai.19.3.999-1012.1978

Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells.

M Chinchilla, J K Frenkel
PMCID: PMC422290  PMID: 640741

Abstract

Antigen-treated lymphocytes from immune hamsters specifically protected not only macrophages, but also cultured fibroblasts and kidney cells infected with Toxoplasma gondii or Besnoitia jellisoni. Macrophages were not necessary for the protection of fibroblasts and kidney cells. A mediator that inhibited the intracellular proliferation of these microbes was obtained from immune lymphocytes in contact with specific antigen. Again, macrophages were not necessary for the elaboration of this mediator or its activity in kidney cells or fibroblasts. The mediator was microbe and host specific, had a molecular weight between 4,000 and 5,000, was resistant to heating at 56 degrees C for 30 min, and was sensitive to chymotrypsin, but resistant to ribonuclease and deoxyribonuclease. A single injection of Besnoitia mediator afforded better protection to hamsters infected with Besnoitia than did antibody. Whereas antibody lysed extracellular organisms, the microbe-specific mediators conferred immunity not only on macrophages, but also on other cells of the body, apparently the first such demonstration.

Full text

PDF
999

Images in this article

1006Image
on p.1006

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN W. P. Immunity against tularemia: passive protection of mice by transfer of immune tissues. J Exp Med. 1962 Feb 1;115:411–420. doi: 10.1084/jem.115.2.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aikawa M., Komata Y., Asai T., Midorikawa O. Transmission and scanning electron microscopy of host cell entry by Toxoplasma gondii. Am J Pathol. 1977 May;87(2):285–296. [PMC free article] [PubMed] [Google Scholar]
  3. Alexander P., Evans R., Grant C. K. The interplay of lymphoid cells and macrophages in tumour immunity. Ann Inst Pasteur (Paris) 1972 Apr;122(4):645–658. [PubMed] [Google Scholar]
  4. Anderson S. E., Bautista S., Remington J. S. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J Immunol. 1976 Aug;117(2):381–387. [PubMed] [Google Scholar]
  5. Bast R. C., Jr, Cleveland R. P., Littman B. H., Zbar B., Rapp H. J. Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. Cell Immunol. 1974 Feb;10(2):248–259. doi: 10.1016/0008-8749(74)90116-6. [DOI] [PubMed] [Google Scholar]
  6. Biesecker J. L. Cellular and humoral immunity after allogeneic transplantation in the rat. I. Cellular and humoral immunity of measured by a 51 Cr cytotoxicity assay after allogeneic tumor and renal transplantation. Transplantation. 1973 Mar;15(3):298–307. doi: 10.1097/00007890-197303000-00006. [DOI] [PubMed] [Google Scholar]
  7. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971 May 1;133(5):1074–1089. doi: 10.1084/jem.133.5.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bommer W., Heunert H. H., Milthaler B. Kinematographische Studien über die Eigenbewegung von Toxoplasma gondii. Z Tropenmed Parasitol. 1969 Dec;20(4):450–458. [PubMed] [Google Scholar]
  9. Borges J. S., Johnson W. D., Jr Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products. J Exp Med. 1975 Feb 1;141(2):483–496. doi: 10.1084/jem.141.2.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Campbell P. A. Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev. 1976 Jun;40(2):284–313. doi: 10.1128/br.40.2.284-313.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FRENKEL J. K., JACOBS L. Ocular toxoplasmosis; pathogenesis, diagnosis and treatment. AMA Arch Ophthalmol. 1958 Feb;59(2):260–279. [PubMed] [Google Scholar]
  12. Frenkel J. K. Adoptive immunity to intracellular infection. J Immunol. 1967 Jun;98(6):1309–1319. [PubMed] [Google Scholar]
  13. Frenkel J. K., Caldwell S. A. Specific immunity and nonspecific resistance to infection: listeria, protozoa, and viruses in mice and hamsters,. J Infect Dis. 1975 Mar;131(3):201–209. doi: 10.1093/infdis/131.3.201. [DOI] [PubMed] [Google Scholar]
  14. Frenkel J. K., Lunde M. N. Effects of corticosteroids on antibody and immunity in Besnoitia infection of hamsters. J Infect Dis. 1966 Oct;116(4):414–424. doi: 10.1093/infdis/116.4.414. [DOI] [PubMed] [Google Scholar]
  15. Frenkel J. K., Nelson B. M., Arias-Stella J. Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects. Hum Pathol. 1975 Jan;6(1):97–111. doi: 10.1016/s0046-8177(75)80111-0. [DOI] [PubMed] [Google Scholar]
  16. Frenkel J. K., Wilson H. R. Effects of radiation on specific cellular immunities: besnoitiosis and a herpesvirus infection of hamsters. J Infect Dis. 1972 Mar;125(3):216–230. doi: 10.1093/infdis/125.3.216. [DOI] [PubMed] [Google Scholar]
  17. Hamada C., Uetake H. Mechanism of induction of cell-mediated immunity to virus infections: in vitro inhibition of intracellular multiplication of mouse adenovirus by immune spleen cells. Infect Immun. 1975 May;11(5):937–943. doi: 10.1128/iai.11.5.937-943.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hoff R. L., Frenkel J. K. Cell-mediated immunity against Besnoitia and toxoplasma in specifically and cross-immunized hamsters and in cultures. J Exp Med. 1974 Mar 1;139(3):560–580. doi: 10.1084/jem.139.3.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Howard D. H., Otto V., Gupta R. K. Lymphocyte-mediated cellular immunity in histoplasmosis. Infect Immun. 1971 Nov;4(5):605–610. doi: 10.1128/iai.4.5.605-610.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jones T. C., Len L., Hirsch J. G. Assessment in vitro of immunity against Toxoplasma gondii. J Exp Med. 1975 Feb 1;141(2):466–482. doi: 10.1084/jem.141.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jones T., Youmans G. P. The in vitro inhibition of growth of intracellular Listeria monocytogenes by lymphocyte products. Cell Immunol. 1973 Dec;9(3):353–362. doi: 10.1016/0008-8749(73)90050-6. [DOI] [PubMed] [Google Scholar]
  22. KAUFMAN H. E., MALONEY E. D. Multiplication of three strains of Toxoplasma gondii in tissue culture. J Parasitol. 1962 Jun;48:358–361. [PubMed] [Google Scholar]
  23. Lefford M. J., McGregor D. D., Mackaness G. B. Immune response to Mycobacterium tuberculosis in rats. Infect Immun. 1973 Aug;8(2):182–189. doi: 10.1128/iai.8.2.182-189.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lindberg R. E., Frenkel J. K. Cellular immunity to toxoplasma and besnoitia in hamsters: specificity and the effects of cortisol. Infect Immun. 1977 Mar;15(3):855–862. doi: 10.1128/iai.15.3.855-862.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lodmell D. L., Niwa A., Hayashi K., Notkins A. L. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med. 1973 Mar 1;137(3):706–720. doi: 10.1084/jem.137.3.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mills J. A. Characterization of guinea pig mitogenic factor. J Immunol. 1975 Jan;114(1 Pt 1):45–50. [PubMed] [Google Scholar]
  28. North R. J. Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production. J Exp Med. 1973 Aug 1;138(2):342–355. doi: 10.1084/jem.138.2.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pang T., Blanden R. V. The cell-mediated immune response to ectromelia virus infection. Secondary response in vitro: specificity, nature of effector and responder cells and requirements for induction of antigenic changes in stimulator cells. Aust J Exp Biol Med Sci. 1976 Jun;54(3):253–264. [PubMed] [Google Scholar]
  30. Patterson R. J., Youmans G. P. Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun. 1970 Jun;1(6):600–603. doi: 10.1128/iai.1.6.600-603.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Remington J. S., Krahenbuhl J. L., Mendenhall J. W. A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun. 1972 Nov;6(5):829–834. doi: 10.1128/iai.6.5.829-834.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rocklin R. E., MacDermott R. P., Chess L., Schlossman S. F., David J. R. Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974 Nov 1;140(5):1303–1316. doi: 10.1084/jem.140.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ruskin J., McIntosh J., Remington J. S. Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969 Aug;103(2):252–259. [PubMed] [Google Scholar]
  34. SEVER J. L. Passive transfer of resistance to tuberculosis through use of monocytes. Proc Soc Exp Biol Med. 1960 Feb;103:326–329. doi: 10.3181/00379727-103-25506. [DOI] [PubMed] [Google Scholar]
  35. Sabin A. B., Feldman H. A. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science. 1948 Dec 10;108(2815):660–663. doi: 10.1126/science.108.2815.660. [DOI] [PubMed] [Google Scholar]
  36. Sethi K. K., Pelster B., Suzuki N., Piekarski G., Brandis H. Immunity to Toxoplasma gondii induced in vitro in non-immune mouse macrophages with specifically immune lymphocytes. J Immunol. 1975 Oct;115(4):1151–1158. [PubMed] [Google Scholar]
  37. Shirahata T., Shimizu K., Noda S., Suzuki N. Studies on production of biologically active substance which inhibits the intracellular multiplication of Toxoplasma within mouse macrophages. Z Parasitenkd. 1977 Aug 25;53(1):31–40. doi: 10.1007/BF00383112. [DOI] [PubMed] [Google Scholar]
  38. Shirahata T., Shimizu K., Suzuki N. An in vitro study on lymphocyte-mediated immunity in mice experimentally infected with Toxoplasma gondii. Nihon Juigaku Zasshi. 1975 Jun;37(3):235–243. doi: 10.1292/jvms1939.37.235. [DOI] [PubMed] [Google Scholar]
  39. Shirahata T., Shimizu K., Suzuki N. Effects of immune lymphocyte products and serum antibody on the multiplication of Toxoplasma in murine peritoneal macrophages. Z Parasitenkd. 1976 Mar 31;49(1):11–23. doi: 10.1007/BF00445014. [DOI] [PubMed] [Google Scholar]
  40. Stadtsbaeder S., Nguyen B. T., Calvin-Preval M. C. Respective role of antibodies and immune macrophages during acquired immunity against toxoplasmosis in mice. Ann Immunol (Paris) 1975 Jun-Jul;126C(4):461–474. [PubMed] [Google Scholar]
  41. Swartzberg J. E., Krahenbuhl J. L., Remington J. S. Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infect Immun. 1975 Nov;12(5):1037–1043. doi: 10.1128/iai.12.5.1037-1043.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES